Clinical trial
Polycystic Ovary Syndrome - Targeting the Sympathetic Nervous System to Improve Outcomes
NCT01504321 is registered in ClinicalTrials.gov with Baker Heart and Diabetes Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Polycystic Ovary Syndrome - Targeting the Sympathetic Nervous System to Improve Outcomes
- Lead sponsor
- Baker Heart and Diabetes Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- December 31, 2015
- Enrollment
- 42 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.